Neurovalens raises £2.1M in funding and gains FDA approval for anxiety treatment wearable device
Amount Raised
£2.1 Million
Round Type
Seed
BelfastManufacturingBiotechnologyHealth CareMedicalMedical DeviceDescription
Belfast-based healthtech company Neurovalens announced that it has closed a £2.1 million funding round with existing investors and gained FDA approval for its Modius Stress device, designed to treat anxiety by delivering noninvasive electrical stimulation to the head.
Quick answer
Neurovalens raised £2.1 Million in a Seed round, dated April 8, 2024. Neurovalens is based in Belfast, Northern Ireland, United Kingdom.
- How much did Neurovalens raise?
- Neurovalens raised £2.1 Million in a Seed round on April 8, 2024.
- What does Neurovalens do?
- Neurovalens is a healthtech company based in Belfast, specializing in combining neuroscience and technology to tackle global health challenges.
- Where is Neurovalens based and how big is it?
- Neurovalens is based in Belfast, Northern Ireland, United Kingdom. Fundz records about 30 employees.
- Who are the decision-makers at Neurovalens?
- Fundz holds 2 contacts at Neurovalens. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Neurovalens, and when
A new round usually means Neurovalens is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Neurovalens raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Neurovalens, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Neurovalens. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Neurovalens raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Neurovalens raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.